Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19
Clinical trial NCT04351659 · UNKNOWN
Trial details
- NCT number
- NCT04351659
- Sponsor
- KK Women's and Children's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-14
- Primary completion
- 2022-09-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.